Meet the tree that could save Florida's citrus industry
Matt Mattia used both hands to flip through the branch at his eye level, studying each side of every leaf as sunlight filtered from above.
'Just healthy leaves,' he said, noting the dark green color.
He turned his attention to a young fruit that was still the same color as the leaf next to it.
'That looks pretty symmetrical,' he said, plucking it for further examination. 'That should develop into a nice, big orange.'
Mattia is no farmer, and the tree was no ordinary plant. He works for the United States Department of Agriculture as a geneticist. The tree has a name: Donaldson.
Mattia called it the most researched tree in the state of Florida. It's also the tree that growers hope will save the state's citrus industry.
'When I saw the Donaldson tree, I was like, 'Wow, this is something that's really unique and really different,'' Mattia said.
Donaldson's notoriety has come from its unique combination of three attributes: its status as a genetically pure orange tree, its sweet taste, and most importantly, its resistance to the Huanglongbing disease, more commonly known as HLB or 'greening.'
Since arriving in the United States from Brazil, greening has killed groves across the state of Florida and contributed to a 90% decline in citrus production over the past 20 years. Leaves of infected trees appear splotchy in color and can be abnormally shaped. The tree's fruit also takes on irregular characteristics – until the tree dies.
While it has infected almost every variety of citrus tree, it hit one of two types of orange trees particularly hard: the Hamlin variety, which fruits early in the winter before the late-season Valencia oranges came in.
Under FDA rules, Hamlins and Valencias are the two major types of oranges that are allowed to be used for Florida orange juice, Mattia explained. Without the Hamlin trees, growers' profits suffered.
Donaldson is also an early season tree. It was planted 30 years ago when the USDA created its Groveland research farm with different citrus varieties that growers could fall back on, like a seed bank.
Mattia found it by sampling 25,000 different trees to test for infection and fruit sweetness. He found other trees tolerated greening, but their fruit was bitter, bordering on inedible, he recalled.
Donaldson, with its high sugar content, stood out.
A Hamlin tree was planted near Donaldson at the same time. Mattia pointed at the spot, which was nothing more than the remnant of a trunk sticking out of the ground and a pink ribbon tied around it.
Greening did most of the damage, and Hurricane Milton finished it off, he said.
'It just was a huge stark contrast between something that was really very, very sick and declining and something that appears to continue to produce a regular crop,' he explained. 'We took the fruit, we sampled the fruit, and we tasted it, and we were like, wow, this has industry potential.'
Now that they've settled on a tree, Mattia and his team have been figuring out what it would take to make Donaldson a commercial success.
Several researchers analyzed the taste, which to the average palette is identical to Hamlin and Valencia. The best method to produce orange juice was also looked at, with Mattia opening a bottle that had been created using a method new to their research.
Mattia's team is now working on the next phase of their testing: monitoring young Donaldsons that had been grafted onto dozens of different rootstocks to see which combination of plants grow the strongest and fastest.
One Hamlin tree planted among the Donaldsons as a control showed signs of greening infection. Mattia said it was highly likely many of the healthy-looking nine-month-old plants had already been hit, though as a researcher it only helped him get further to his goal.
But the USDA isn't gate-keeping Donaldson, even though the tree itself is grown behind fences and locks.
'We're pushing it out to commercial usage,' Mattia said. 'If people want to test it in their own grove, it's available, and we have the data and the research going on here that supports that effort.'
Florida is already on-board. Mattia said the state has propagated 18,000 Donaldsons that it's sending to growers across the state to accelerate the adoption effort.
One of those potentially interested is Mary Graham, owner of Graham's U-Pick Farms, who had heard of Donaldson and wanted to know how many seeds each fruit had (five to seven) and whether the fruit was edible when freshly picked (yes).
For a century, Graham's specialized in oranges. As of this year, they only grow peaches.
'We noticed greening hitting our grove probably about 15 years ago,' she recalled. 'About 10, 12, years ago, it started getting a little more aggressive. So at that point, we looked for an alternative crop.'
Like her neighbors, Graham tried different methods to save her trees. She and her husband added more nutrients to the soil and cut down on chemicals, which she said helped the trees recover.
Eventually, the disease won the battle, and her husband tore out the last of the trees in January. She's looking to plant new seedlings for her children to eventually care for, even though she said her peaches were better for business.
'We're hopeful about the Donaldson tree,' she said. 'With that one, what else can they come up with?'
That's what Mattia is all about. He previewed 'future orange juice,' a blend of different citrus fruits that resembles orange juice but has a notable flavor difference that's being created as an alternative to Donaldson in case the tree doesn't work out.
'My mission is to really help people,' he said. 'So if they, if the industry and the processors find utility from this tree, I feel like our mission is accomplished.'
Click here to download our free news, weather and smart TV apps. And click here to stream Channel 9 Eyewitness News live.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
39 minutes ago
- Yahoo
The Most Consumed Veggie in the U.S. Is Full of Pesticides
You've probably heard of the "Dirty Dozen" list. Each year, the Environmental Working Group (EWG) uses data from the USDA to pinpoint the produce with the most pesticides. Last year, strawberries have took the lead. But in the new Shopper's Guide to Pesticides in Produce, which was released on June 12, strawberries have been knocked out of their number one spot. And there are two newcomers to the list. So what's the "dirtiest" fruit or veggie? In this year's list, spinach swapped places with strawberries for the number one spot. The leafy green was found to have "more pesticide residues by weight than any other type of produce," according to the site. And the samples contained more pesticides by weight than any other produce. 75% of non-organic samples contained permethrin, a neurotoxic insecticide banned in Europe. New to the list are blackberries, which were tested by the USDA for the first time in 2023. And, potatoes, the most-consumed vegetable in the country, also made it to the Dirty Dozen. 90% of potato samples tested positive for chlorpropham, a chemical that prevents sprout growth—and a chemical that's banned in the European Union. "EWG's Shopper's Guide is a tool to inform consumers and help them with their produce shopping choices, with the goal of everyone eating more fruits and vegetables,' says Alexis Temkin, Ph.D., EWG Vice President for Science, in the press release. Other fruits and veggies that made it to the Dirty Dozen include dark leafy greens such as kale, collard greens, and mustard greens; grapes; peaches; cherries; nectarines; pears; and apples. Produce with the lowest amounts of pesticide residue made it to the "Clean Fifteen." The top five include pineapples, sweet corn, avocados, papayas, and onions. To determine the list, the EWG looks at pesticide residue from tests performed by the USDA. These tests included over 53,000 samples of 47 washed fruits and vegetables. This year's list used a new methodology to get a more accurate depiction of just how harmful dirty some fruits and veggies may be. In addition to the amount of pesticides, the study looked at toxicity, meaning how harmful the pesticides could be. 'Our research takes into account the potency of each chemical and can help shoppers reduce their overall pesticide burden," says Dayna de Montagnac, M.P.H., an associate scientist for the EWG. You Might Also Like 67 Best Gifts for Women That'll Make Her Smile The Best Pillows for Every Type of Sleeper
Yahoo
an hour ago
- Yahoo
KalVista Pharmaceuticals Announces FDA Will Not Meet PDUFA Goal Date for Sebetralstat NDA for Hereditary Angioedema Due to FDA Resource Constraints
FDA states heavy workload and limited resources prevent meeting PDUFA goal date of June 17 Agency indicates anticipated decision within four weeks CAMBRIDGE, Mass. & SALISBURY, England, June 13, 2025--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that it will not meet the PDUFA goal date for the New Drug Application (NDA) for sebetralstat, the Company's investigational oral on-demand treatment for hereditary angioedema (HAE). The FDA notified the Company on June 13, 2025, that the previously disclosed June 17, 2025 PDUFA goal date will not be met due to heavy workload and limited resources. The FDA indicated that it expects to deliver a decision within approximately four weeks. The FDA has not requested additional data or studies and has not raised any concerns regarding the safety, efficacy or approvability of sebetralstat. KalVista has addressed all prior information requests in a timely manner, and the Company believes the only remaining item under FDA review is the finalization of the labelling. "We are disappointed by this delay, most importantly because we know how much people living with HAE are looking forward to an oral on-demand option to treat their HAE attacks," said Ben Palleiko, CEO of KalVista. "At the same time, we remain confident in the near-term approval of sebetralstat. We are continuing to work closely with the FDA to support the completion of their review. Our commitment to bringing this important therapy to people living with HAE remains unwavering." About Sebetralstat Sebetralstat is an investigational, novel oral plasma kallikrein inhibitor for the treatment of hereditary angioedema (HAE). We have filed multiple regulatory applications seeking approval of sebetralstat as the first oral, on-demand treatment for HAE in individuals aged 12 and older and are investigating its use in children aged 2 to 11. If approved, sebetralstat has the potential to become the foundational therapy for HAE management worldwide. About Hereditary Angioedema Hereditary angioedema (HAE) is a rare genetic disease resulting in deficiency or dysfunction in the C1 esterase inhibitor (C1INH) protein and subsequent uncontrolled activation of the kallikrein-kinin system. People living with HAE experience painful and debilitating attacks of tissue swelling in various locations of the body that can be life-threatening depending on the area affected. All currently approved on-demand treatment options require either intravenous or subcutaneous administration. About KalVista Pharmaceuticals, Inc. KalVista Pharmaceuticals, Inc., is a global biopharmaceutical company dedicated to developing and delivering life-changing oral therapies for individuals affected by rare diseases with significant unmet needs. Our lead investigational product is sebetralstat, a novel, oral, on-demand treatment for hereditary angioedema (HAE). Sebetralstat is under regulatory review by the U.S. FDA. In addition, we have completed Marketing Authorization Applications for sebetralstat to the European Medicines Agency and multiple other global regulatory authorities. For more information about KalVista, please visit or follow us on social media at @KalVista and LinkedIn. Forward-Looking Statements This press release contains "forward-looking" statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "will" and similar references to future periods. These statements are subject to numerous risks and uncertainties that could cause actual results to differ materially from what we expect. Examples of forward-looking statements include, among others, timing or outcomes of communications with the FDA, our expectations about safety and efficacy of our product candidates and timing of clinical trials and its results, our ability to commence clinical studies or complete ongoing clinical studies, including our KONFIDENT-S and KONFIDENT-KID trials, and to obtain regulatory approvals for sebetralstat and other candidates in development, the success of any efforts to commercialize sebetralstat, the ability of sebetralstat and other candidates in development to treat HAE or other diseases, and the future progress and potential success of our oral Factor XIIa program. Further information on potential risk factors that could affect our business and financial results are detailed in our filings with the Securities and Exchange Commission, including in our annual report on Form 10-K for the year ended April 30, 2024, our quarterly reports on Form 10-Q, and our other reports that we may make from time to time with the Securities and Exchange Commission. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise. View source version on Contacts Ryan BakerHead, Investor Relations(617) Molly CameronDirector, Corporate Communications(978) Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


CNN
an hour ago
- CNN
Ground beef sold at Whole Foods might be contaminated with E. coli, USDA warns
The US Department of Agriculture's Food Safety and Inspection Service has issued a public health alert for some raw ground beef products sold at Whole Foods Market because of a risk of E. coli contamination. The products are 1-pound, vacuum-packed packages of Organic Rancher organic 85% lean and 15% fat ground beef with use- or freeze-by dates of June 19 or June 20. They came from Vermont-based NPC Processing and have an establishment number Est. 4027 inside the USDA mark of inspection. The raw ground beef is no longer available for purchase, but FSIS says it's concerned that the packages may still be in consumers' refrigerators or freezers. They should not be used and should be thrown away or returned to the place of purchase. According to FSIS, there have been no confirmed reports of illnesses related to these products, but people should contact a health care provider if they're concerned. Organic Rancher says the products were available from May 26 through June 3 in the following states: Alabama, Connecticut, Florida, Georgia, Iowa, Illinois, Indiana, Kentucky, Massachusetts, Maryland, Maine, Michigan, Minnesota, Missouri, Mississippi, North Carolina, New Hampshire, New Jersey, New York, Ohio, Pennsylvania, Rhode Island, South Carolina, Tennessee, Virginia and Wisconsin, as well as the District of Columbia. Other states were not affected, it says, and products with different use- or freeze-by dates are not involved and are safe to use. E. coli is a potentially deadly bacterium that can cause dehydration, bloody diarrhea and abdominal cramps for two to eight days after exposure. Although most people recover within a week, some may develop a serious complication called hemolytic uremic syndrome, which can lead to kidney failure or death. It can happen in any age group but is most common in children younger than 5 and older adults. 'The root cause of the issue has been identified, and immediate corrective actions have been put in place to ensure the ongoing integrity of the Organic Rancher brand,' the company said in its alert. 'We are treating this matter with the utmost seriousness and are fully committed to ensuring the safety and satisfaction of our customers.' FSIS emphasizes that all consumers should consume only ground beef that has been cooked to a temperature of 160 degrees Fahrenheit, and the only way to confirm that ground beef has reached a temperature high enough to eliminate harmful bacteria is to use a food thermometer that can measure internal temperature.